Cdk12 is essential for embryonic development and the maintenance of genomic stability

Cell Death and Differentiation

Volumn 23, Issue 6, 2016, Pages 1038-1048

  Juan, H C ^a   Lin, Y ^a   Chen, H R ^a   Fann, M J ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 12; UNCLASSIFIED DRUG; ATM PROTEIN; ATR PROTEIN, MOUSE; BRCA1 PROTEIN; CDK12 PROTEIN, MOUSE; FANCI PROTEIN, MOUSE; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, MOUSE; TRP53BP1 PROTEIN, MOUSE; TUMOR SUPPRESSOR P53 BINDING PROTEIN 1;

ADULT; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLASTOCYST; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; EMBRYO; EMBRYO CELL; EMBRYO DEVELOPMENT; FEMALE; GENOMIC INSTABILITY; GENOTYPE; IN VITRO STUDY; INNER CELL MASS; KNOCKOUT MOUSE; LETHALITY; MOLECULAR MECHANICS; MOUSE; MOUSE EMBRYO; NIDATION; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN DEPLETION; ANIMAL; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DEFICIENCY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; APOPTOSIS; ATAXIA TELANGIECTASIA MUTATED PROTEINS; BLASTOCYST; BRCA1 PROTEIN; CELLS, CULTURED; CYCLIN-DEPENDENT KINASES; DNA REPAIR; EMBRYONIC DEVELOPMENT; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; GENOMIC INSTABILITY; GENOTYPE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OCTAMER TRANSCRIPTION FACTOR-3; TUMOR SUPPRESSOR P53-BINDING PROTEIN 1;

EID: 84949604125     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.157     Document Type: Article

References (36)

1. Papaioannou VE. Lineage analysis of inner cell mass and trophectoderm using microsurgically reconstituted mouse blastocysts. J Embryol Exp Morphol 1982; 68: 199-209
2. De Waard H, De Wit J, Gorgels TG, Van den Aardweg G, Andressoo JO, Vermeij M., et al. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair (Amst) 2003; 2: 13-25
3. Van Sloun PP, Jansen JG,Weeda G, Mullenders LH, Van Zeeland AA, Lohman PH., et al. The role of nucleotide excision repair in protecting embryonic stem cells from genotoxic effects of UV-induced DNA damage. Nucleic Acids Res 1999; 27: 3276-3282
4. Khanna KK, Jackson SP. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27: 247-254
5. Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res 2008; 18: 99-113
6. Francis R, Richardson C. Multipotent hematopoietic cells susceptible to alternative doublestrand break repair pathways that promote genome rearrangements. Genes Dev 2007; 21: 1064-1074
7. Yang YG, Cortes U, Patnaik S, Jasin M, Wang ZQ. Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks. Oncogene 2004; 23: 3872-3882
8. Tsuzuki T, Fujii Y, Sakumi K, Tominaga Y, Nakao K, Sekiguchi M., et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc Natl Acad Sci USA 1996; 93: 6236-6240
9. Luo G, Yao MS, Bender CF, Mills M, Bladl AR, Bradley A., et al. Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci USA 1999; 96: 7376-7381
10. Liu CY, Flesken-Nikitin A, Li S, Zeng Y, Lee WH. Inactivation of the mouse Brca1 gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes Dev 1996; 10: 1835-1843
11. Brown EJ, Baltimore D. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 2000; 14: 397-402
12. Chen HH, Wang YC, Fann MJ. Identification and characterization of the CDK12/cyclin L1 complex involved in alternative splicing regulation. Mol Cell Biol 2006; 26: 2736-2745
13. Cheng SW, Kuzyk MA, Moradian A, Ichu TA, Chang VC, Tien JF., et al. Interaction of cyclindependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase II. Mol Cell Biol 2012; 32: 4691-4704
14. Blazek D, Kohoutek J, Bartholomeeusen K, Johansen E, Hulinkova P, Luo Z., et al. The cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes. Genes Dev 2011; 25: 2158-2172
15. Dai Q, Lei T, Zhao C, Zhong J, Tang YZ, Chen B., et al. Cyclin K-containing kinase complexes maintain self-renewal in murine embryonic stem cells. J Biol Chem 2012; 287: 25344-25352
16. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E., et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165-171
17. Sircoulomb F, Bekhouche I, Finetti P, Adelaide J, Ben Hamida A, Bonansea J., et al. Genome profiling of ERBB2-Amplified breast cancers. BMC Cancer 2010; 10: 539
18. Zang ZJ, Ong CK, Cutcutache I, Yu W, Zhang SL, Huang D., et al. Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing. Cancer Res 2011; 71: 29-39
19. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609-615
20. Carter SL, Cibulskis K, Helman E, McKenna A, Shen H, Zack T., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012; 30: 413-421
21. Joshi PM, Sutor SL, Huntoon CJ, Karnitz LM. Ovarian cancer-Associated mutations disable catalytic activity of CDK12, a kinase that promotes homologous recombination repair and resistance to cisplatin and poly(ADP-ribose) polymerase inhibitors. J Biol Chem 2014; 289: 9247-9253
22. Ekumi KM, Paculova H, Lenasi T, Pospichalova V, Bosken CA, Rybarikova J., et al. Ovarian carcinoma CDK12 mutations misregulate expression of DNA repair genes via deficient formation and function of the Cdk12/CycK complex. Nucleic Acids Res 2015; 43: 2575-2589
23. Chen HR, Lin GT, Huang CK, Fann MJ. Cdk12 and Cdk13 regulate axonal elongation through a common signaling pathway that modulates Cdk5 expression. Exp Neurol 2014; 261: 10-21
24. O'Gorman S, Dagenais NA, Qian M, Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci USA 1997; 94: 14602-14607
25. Lewandoski M, Wassarman KM, Martin GR. Zp3-cre, a transgenic mouse line for the activation or inactivation of loxP-flanked target genes specifically in the female germ line. Curr Biol 1997; 7: 148-151
26. Dietrich JE, Hiiragi T. Stochastic patterning in the mouse pre-implantation embryo. Development 2007; 134: 4219-4231
27. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev 2003; 17: 126-140
28. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J Cell Biol 2000; 151: 1381-1390
29. MacAuley A, Cross JC, Werb Z. Reprogramming the cell cycle for endoreduplication in rodent trophoblast cells. Mol Biol Cell 1998; 9: 795-807
30. Ullah Z, Kohn MJ, Yagi R, Vassilev LT, DePamphilis ML. Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity. Genes Dev 2008; 22: 3024-3036
31. Marnett LJ, Plastaras JP. Endogenous DNA damage and mutation. Trends Genet 2001; 17: 214-221
32. Larson JS, Stringer SL, Stringer JR. Impact of mismatch repair deficiency on genomic stability in the maternal germline and during early embryonic development. Mutat Res 2004; 556: 45-53
33. Xu Q, Wang F, Xiang Y, Zhang X, Zhao Z, Gao Z., et al. Maternal BCAS2 protects genomic integrity in mouse early embryonic development. Development 2015; 142: 3943-3953
34. Chen HH, Wong YH, Geneviere AM, Fann MJ. CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. Biochem Biophys Res Commun 2007; 354: 735-740
35. Natrajan R, Wilkerson PM, Marchio C, Piscuoglio S, Ng CK, Wai P., et al. Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast. J Pathol 2014; 232: 553-565
36. Bajrami I, Frankum JR, Konde A, Miller RE, Rehman FL, Brough R., et al. Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity. Cancer Res 2014; 74: 287-297